Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.18.351216128728.0156
Domestic EquitiesDivi's Laboratories Ltd.8.12321935112.4011
Domestic EquitiesMAX Healthcare Institute Ltd8.102011327312.3688
Domestic EquitiesApollo Hospitals Enterprise Ltd.8.03191567712.2618
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.82119282411.9400
Domestic EquitiesCipla Ltd.7.56878570511.5547
Domestic EquitiesLupin Ltd.5.5672369228.4991
Domestic EquitiesFortis Healthcare Ltd.4.9015793807.4828
Domestic EquitiesTorrent Pharmaceuticals Ltd.4.5211159286.9021
Domestic EquitiesLaurus Labs Ltd.4.1707591856.3671
Domestic EquitiesAurobindo Pharma Ltd.3.4063426115.2002
Domestic EquitiesAlkem Laboratories Ltd.3.291489105.0248
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.2100229354.9005
Domestic EquitiesBiocon Ltd.2.77581087134.2376
Domestic EquitiesMankind Pharma Ltd.2.5362172273.8719
Domestic EquitiesZydus Lifesciences Ltd.2.3016381223.5137
Domestic EquitiesIPCA Laboratories Ltd.2.1211211803.2382
Domestic EquitiesAbbott India Ltd.1.37647922.1012
Domestic EquitiesPiramal Pharma Ltd.0.9640942581.4717
Domestic EquitiesSyngene International Ltd.0.7994289061.2204
Total 99.9410 152.5733
Cash & Cash Equivalents and Net AssetsTREPS0.5076 0.7749
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.4486 -0.6849
Total 0.0590 0.0900
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.